Professor, Laboratory Medicine and Pathology, Mayo Medical School

Pathology

Dr. Caterina Giannini, MD

Caterina Giannini practices Pathology. Dr. Caterina Giannini is a published physician. She published 43 publications, including: 'NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.' She accepts Medicare payments and is registered with Medicare.gov.

Publications

NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.
Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia.
Adult primary central nervous system vasculitis treatment and course: Analysis of 163 patients.
Cavernous hemangiomas of the internal auditory canal and cerebellopontine angle.
Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
Pleomorphic Xanthoastrocytoma: Natural History and Long-term Follow-up.
International Society of Neuropathology-Haarlem Consensus Guidelines, for Nervous System Tumor Classification and Grading.
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.
CNS lymphoma: a practical diagnostic approach.
Specific pattern of gadolinium enhancement in spondylotic myelopathy.
Interictal Scalp Electroencephalography and Intraoperative Electrocorticography in Magnetic Resonance Imaging-Negative Temporal Lobe Epilepsy Surgery.
Rhabdoid-like meningioma with inclusions consisting of accumulations of complex interdigitating cell processes rather than intermediate filaments.
Long-term Outcomes and Role of Chemotherapy in Adults With Newly Diagnosed Medulloblastoma.
Adult Low-grade Glioma: 19-year Experience at a Single Institution.
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Long-term Outcomes After Nonlesional Extratemporal Lobe Epilepsy Surgery.
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years.
Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial.
Rim and flame signs: postgadolinium MRI findings specific for non-CNS intramedullary spinal cord metastases.
Brain carcinoid metastases: outcomes and prognostic factors.
Targeting SRC family kinases inhibits bevacizumab-induced glioma cell invasion.
Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
Gliomatosis cerebri: clinical characteristics, management, and outcomes.
The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.
Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic.
Long-Term Outcome of Esthesioneuroblastoma: Hyams Grade Predicts Patient Survival.
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
Scalp and Intracranial EEG in Medically Intractable Extratemporal Epilepsy with Normal MRI.
BRAF Alterations Are Frequent in Cerebellar Low-Grade Astrocytomas With Diffuse Growth Pattern.
Primary central nervous system vasculitis: pathology and mechanisms.
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group...
Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.
Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.
A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.
Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma.

Doctors Specialties

Neuropathology
Pathology

Accepted Insurances

Education

Mayo School of Graduate Medical Education
University of Pisa Faculty of Medicine

Hospital

Mayo Clinic - Rochester, Minnesota

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1043280332
Last Name Of The Provider	GIANNINI
First Name Of The Provider	CATERINA
View All

Similar Doctors

	Dr. Armita Bahrami, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph J. Maleszewski, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Henry A. Homburger, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bernd W. Scheithauer, MD This Doctor is OpenDoctor Recommended.
	Dr. James R. Stubbs, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. William G. Morice, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith J. Kaplan, MD
	Dr. Sanjeev Sethi, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Cristiane M. Ida, MD This Doctor is OpenDoctor Recommended.
	Aditya Raghunathan, MB This Doctor is OpenDoctor Recommended.
	Dr. Marosh Manduch, MD This Doctor is OpenDoctor Recommended.
	Derick M. Aranda, MB BS
	Dr. Rachael A. Vaubel, MD This Doctor is OpenDoctor Recommended.